Bloomberg's Acquisition of Barclays Point: Any Port in a Storm?

Bloomberg's acquisition of the Barclays Port intellectual property has caused a storm in the fixed-income technology space for investment firms and vendors alike.

The acquisition of intellectual property (IP) rights are often tangled, complicated affairs that can lack the brutal efficacy of outright, wholesale acquisitions. Once you’ve acquired the rights to the IP, what do you do with it to ensure that the deal is a success?

Bloomberg’s acquisition of the Barclays Risk and Indices Solutions (Brais) business, first announced in late 2015 and completed in August last year, has already been the cause of substantial changes in the fixed-income technology

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

A tech revolution in an old-school industry: FX

FX is in a state of transition, as asset managers and financial firms explore modernizing their operating processes. But manual processes persist. MillTechFX’s Eric Huttman makes the case for doubling down on new technology and embracing automation to increase operational efficiency in FX.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here